Yüklüyor......
Evaluation of immunomodulatory drugs in multiple myeloma: single center experience
Objective: Multiple myeloma (MM) comprises 1% of all cancers and 10% of hematologic malignancies and known as an incurable disease. The introduction of immunomodulatory drugs (IMiDs) has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and relapsed/refractory MM pati...
Kaydedildi:
| Yayımlandı: | Am J Blood Res |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
e-Century Publishing Corporation
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769352/ https://ncbi.nlm.nih.gov/pubmed/27069758 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|